Sarepta Therapeutics Inc (SRPT)
118.97
-0.50
(-0.42%)
USD |
NASDAQ |
Dec 20, 16:00
119.11
+0.14
(+0.12%)
After-Hours: 20:00
Sarepta Therapeutics Total Assets (Quarterly): 3.600B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals Inc | 1.140B |
| Eli Lilly and Co | 75.61B |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Catalyst Pharmaceuticals Inc | 772.01M |
| Vertex Pharmaceuticals Inc | 22.24B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.379B |
| Shareholders Equity (Quarterly) | 1.221B |
| Debt to Equity Ratio | 1.005 |
| Current Ratio | 3.839 |
| Net Debt Paydown Yield | 0.01% |